---
document_datetime: 2025-07-29 15:06:50
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/xgeva-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: xgeva-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.145253
conversion_datetime: 2025-12-31 05:28:07.326349
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## XGEVA

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                         |
|----------------------|------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------|
| Variation type IB /  | C.I HUMAN AND VETERINARY MEDICINAL | 29/07/2025                          |                                             | SmPC                             | To amend Section 3 of the SmPC to differentiate |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000280127   | PRODUCTS - C.I.z Other variation - Accepted C.I.z (Type IB) - To amend Section 3 of the SmPC to differentiate between the two registered pharmaceutical forms: vial and pre-filled syringe.   | between the two registered pharmaceutical forms: vial and pre-filled syringe.   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------|